NYSE American warns China Pharma of delisting; avg price below $0.20, cure by March 2024

CHINA PHARMA HOLDINGS, INC.

On Sep 27, 2023, NYSE American notified CPHI of noncompliance: 30-day avg stock price below $0.20.
Company must effect a reverse stock split or demonstrate sustained price improvement by Mar 27, 2024.
Continues to address prior stockholders' equity noncompliance from June 2022.
Listing remains on NYSE American during cure period; business operations unaffected.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.